Development, Marketing, Pharmaceuticals and Tactics

Health Benefits in the Workplace at Risk: Employers Try to Absorb the Shock

HR Digest

SEPTEMBER 16, 2023

markets, particularly nurses, is also of great concern. Pharmaceutical companies and researchers insist that costs have to remain high for the production and further research to be viable. Health benefits in the workplace were a focus for employers last year, as a tactic to attract the right talent and improve their retention rates.

Cost

Cost Pharmaceuticals Price Planning

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics

Tactics Execution Pharmaceuticals Human Capital

Fixing Salespeople's Biggest Complaint: My Territory is Too Small

Harvard Business Review

APRIL 5, 2012

If you spend much time around salespeople, it won't take long before you hear them griping about the issue that is the profession's biggest trouble spot: disagreement over the market potential of a group of accounts or a territory. In exit interviews, the people who leave imply they don't have enough market potential to succeed.".

Retail

Retail Incentives Tactics Pharmaceuticals

Strategic Choices Need to Be Made Simultaneously, Not Sequentially

Harvard Business Review

APRIL 3, 2017

The CEO of a large Australian company called me to relay a particular strategy development problem his firm was facing, and ask for my advice. For example, Uber made a Where to Play choice that included China because it’s a huge and important market. But it didn’t work in the Where to Play of China.

First-mover Advantage

First-mover Advantage Retail Strategy Pharmaceuticals

Seven Ways CEOs and Investors Can Promote the Long Term

Harvard Business Review

SEPTEMBER 29, 2011

They are not interested in hearing about the technological, regulatory, and societal developments that will determine the long-term, strategic positioning of this company.". They can signal to the market the types of investors they wish to own their shares. CEOs can seek to attract long-term investors in several ways: 1.

Long-term

Long-term CEO Short-term Asset Management

New Research: What Sets Effective Middle Managers Apart

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. These MLMs were alienated and felt senior executives had used them as tactical tools.

Middle Management

Middle Management Management Automotive Pharmaceuticals

The Right Kind of Conflict Leads to Better Products

Harvard Business Review

DECEMBER 23, 2016

What distinguished successful from unsuccessful alliances was more of a “productive” irritation — creative tension between differing ideas about how to develop alliance products – reflected in disagreements about the strategy and tactics of how best to develop a particular molecule.

Productivity

Productivity Products Survey Strategic Fit

It’s Time to Rein in Exorbitant Pharmaceutical Prices

Harvard Business Review

SEPTEMBER 22, 2015

As the ire over high prescription drug prices in the United States escalates , it’s easy to blame pharmaceutical companies. But pharmaceutical companies aren’t to blame. The annual expense for a recently developed cancer drug cocktail is $295,000. (No They’ve executed well on the rules set by the U.S.

Pharmaceuticals

Pharmaceuticals Price Budgeting Insurance

Don’t Forget to Connect Customer Service Week with Strategy

Strategy Driven

OCTOBER 10, 2016

Not only does this exposure enhance employees’ perspectives and further their professional development, it also helps to fortify a consistent company-wide culture of service. a boutique company with three distinct, yet complementary, lines of business: outsourced call center services, customer care consulting and marketing services.

Strategy

Strategy Pharmaceuticals Learning-by-Doing Outsourcing

How to Ask for a Raise

Harvard Business Review

MARCH 5, 2015

“But there’s an art to the ask,” says Diana Faison, a partner with leadership development firm Flynn Heath Holt Leadership. You should also avoid “implicitly or explicitly threatening to leave” as a negotiating tactic, says McGinn. What the Experts Say. Look forward, not backward. .

How To

How To Case Study Restructuring Pharmaceuticals

How to Actually Put Your Marketing Data to Use

Harvard Business Review

OCTOBER 27, 2015

In most companies, marketers are in charge of assessing the competition. Because of this, close to 60 percent of all competitive intelligence professionals report to marketing. Yet the majority of marketers fail to use their competition analysts strategically, instead using them to gather more “recon” data.

Marketing

Marketing Competitive Intelligence Porter How To

Enhancing Customer Insights with Public Location Data

Harvard Business Review

JUNE 12, 2018

The pervasive adoption of mobile devices has driven an explosion of contextual user information, including geolocation data, which has become a valuable resource for marketers. However, a lack of technical skill sets among marketers has made it difficult for them to use this data (when they have access to it) effectively.

Short-term

Short-term Brand Long-term Media

The 2010 Execution Round-Up: Six Companies That Couldn't 'Get It.

Strategy Driven

JANUARY 24, 2011

Execution Gap Maker #2: Nokia Nokia’s share of the worldwide market for mobile phones continued to slip in 2010. Why was this once-dominant player unable to execute and maintain its market position? It developed the NOOK and has devoted significant space in its retail stores to display and promote it, and it has a broad online library.

Execution

Execution Company 360-Degree Feedback Cooper

Only Half of Companies Actually Use the Competitive Intelligence They Collect

Harvard Business Review

JANUARY 26, 2016

And yet for almost every company that uses CI in their decision-making, there’s another that disregards CI’s mix of industry analysis, rival positions, and market insight to their detriment. and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields.

Competitive Intelligence

Competitive Intelligence Company CAPEX Analysis

How Pharma Companies Game the System to Keep Drugs Expensive

Harvard Business Review

APRIL 6, 2017

The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. If they brought a new therapy to life, they enjoyed patent protection to effectively monopolize the market. “Authorized generics” are another tactic to limit competition.

System

System Pharmaceuticals Company Sample

Leadership Digital

Health Benefits in the Workplace at Risk: Employers Try to Absorb the Shock

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Trending Sources

Fixing Salespeople's Biggest Complaint: My Territory is Too Small

Strategic Choices Need to Be Made Simultaneously, Not Sequentially

Seven Ways CEOs and Investors Can Promote the Long Term

New Research: What Sets Effective Middle Managers Apart

The Right Kind of Conflict Leads to Better Products

It’s Time to Rein in Exorbitant Pharmaceutical Prices

Don’t Forget to Connect Customer Service Week with Strategy

How to Ask for a Raise

How to Actually Put Your Marketing Data to Use

Enhancing Customer Insights with Public Location Data

The 2010 Execution Round-Up: Six Companies That Couldn't 'Get It.

Only Half of Companies Actually Use the Competitive Intelligence They Collect

How Pharma Companies Game the System to Keep Drugs Expensive

Stay Connected